pefloxacin has been researched along with Pneumococcal Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Potgieter, PD | 1 |
| Baur, C; Davies, BI; Maesen, FP; Teengs, JP | 1 |
2 other study(ies) available for pefloxacin and Pneumococcal Infections
| Article | Year |
|---|---|
Pefloxacin therapy for nosocomial infections in the intensive care unit.
Topics: Cross Infection; Haemophilus Infections; Haemophilus influenzae; Half-Life; Humans; Intensive Care Units; Pefloxacin; Pneumococcal Infections; Streptococcus pneumoniae | 1990 |
[New oral quinolone compounds in chronic bronchitis].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Neisseria; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pneumococcal Infections; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 1986 |